advertisement
Pharmaceuticals (Basel, Switzerland) 18
Showing records 1 to 18 | Display all abstracts in Pharmaceuticals (Basel, Switzerland)112791 Pharmaceutical Approaches to Normal Tension Glaucoma
Salvetat ML
Pharmaceuticals (Basel, Switzerland) 2023; 16:
112589 Immunomodulatory and Antioxidant Drugs in Glaucoma Treatment
Buonfiglio F
Pharmaceuticals (Basel, Switzerland) 2023; 16:
112619 Therapeutic Potential of Cannabinoids in Glaucoma
Lindner T
Pharmaceuticals (Basel, Switzerland) 2023; 16:
113084 Oxidative Stress and Antioxidant-Based Interventional Medicine in Ophthalmology
Honisch C
Pharmaceuticals (Basel, Switzerland) 2023; 16:
112619 Therapeutic Potential of Cannabinoids in Glaucoma
Schmidl D
Pharmaceuticals (Basel, Switzerland) 2023; 16:
113084 Oxidative Stress and Antioxidant-Based Interventional Medicine in Ophthalmology
Rodella U
Pharmaceuticals (Basel, Switzerland) 2023; 16:
112589 Immunomodulatory and Antioxidant Drugs in Glaucoma Treatment
Pfeiffer N
Pharmaceuticals (Basel, Switzerland) 2023; 16:
112791 Pharmaceutical Approaches to Normal Tension Glaucoma
Pellegrini F
Pharmaceuticals (Basel, Switzerland) 2023; 16:
113084 Oxidative Stress and Antioxidant-Based Interventional Medicine in Ophthalmology
Gatto C
Pharmaceuticals (Basel, Switzerland) 2023; 16:
112791 Pharmaceutical Approaches to Normal Tension Glaucoma
Spadea L
Pharmaceuticals (Basel, Switzerland) 2023; 16:
112589 Immunomodulatory and Antioxidant Drugs in Glaucoma Treatment
Gericke A
Pharmaceuticals (Basel, Switzerland) 2023; 16:
112619 Therapeutic Potential of Cannabinoids in Glaucoma
Peschorn L
Pharmaceuticals (Basel, Switzerland) 2023; 16:
113084 Oxidative Stress and Antioxidant-Based Interventional Medicine in Ophthalmology
Ruzza P
Pharmaceuticals (Basel, Switzerland) 2023; 16:
112619 Therapeutic Potential of Cannabinoids in Glaucoma
Pai V
Pharmaceuticals (Basel, Switzerland) 2023; 16:
112791 Pharmaceutical Approaches to Normal Tension Glaucoma
Salati C; Zeppieri M
Pharmaceuticals (Basel, Switzerland) 2023; 16:
112619 Therapeutic Potential of Cannabinoids in Glaucoma
Popa-Cherecheanu A
Pharmaceuticals (Basel, Switzerland) 2023; 16:
113084 Oxidative Stress and Antioxidant-Based Interventional Medicine in Ophthalmology
Tóthová JD
Pharmaceuticals (Basel, Switzerland) 2023; 16:
112619 Therapeutic Potential of Cannabinoids in Glaucoma
Chua J; Schmetterer L; Garhöfer G
Pharmaceuticals (Basel, Switzerland) 2023; 16:
